Evidence-based medicine and the governance of pandemic influenza


Kamradt-Scott, A; (2012) Evidence-based medicine and the governance of pandemic influenza. Global public health, 7 Suppl 2 (SUPPL. 2). S111-26. ISSN 1744-1692 DOI: https://doi.org/10.1080/17441692.2012.728239

Full text not available from this repository. (Request a copy)

Abstract

: The conventional response of governments to protect their populations against the threat of influenza has been to ensure adequate vaccine production and/or access to supplies of vaccines and antiviral medications. This focus has, in turn, shaped the global governance structures around pandemic influenza, with collective efforts centred on facilitating virus sharing, maintaining and increasing vaccine production, and ensuring access to pharmaceuticals - responses that remain unattainable for many low- and middle-income countries (LMICs) in the short to medium term. This paper argues that this emphasis on pharmacological responses reflects a particular view of biomedicine that pays inadequate attention to the weak capacity of many health systems. In more recent years, this dynamic has been further exacerbated by the influence of evidence-based medicine (EBM) that preferences certain types of biomedical knowledge and practice. This paper explores the role that EBM has played in shaping the global governance of pandemic influenza, and how it has served to reinforce and reify the authority of particular groups of actors, including policy-makers, elected officials and the medical community. The paper concludes that only by unpacking these structures and revealing the political authority in play can alternative policy responses more appropriate to LMICs be considered.<br/>

Item Type: Article
Keywords: evidence-based medicine, global health, pandemic influenza, vaccines, virus sharing, influenza vaccine, article, avian influenza virus, evidence based medicine, health care organization, health care policy, health care quality, health care system, human, influenza A (H5N1), Influenza virus A H5N1, knowledge, medical information, priority journal, world health organization, Antiviral Agents, Developing Countries, Health Services Accessibility, Humans, Influenza Vaccines, Influenza, Human, Pandemics, World Health, Antiviral Agents, therapeutic use, Developing Countries, Evidence-Based Medicine, Global Health, Health Services Accessibility, Humans, Influenza Vaccines, supply & distribution, Influenza, Human, epidemiology, prevention & control, transmission, Pandemics
Faculty and Department: Faculty of Public Health and Policy > Dept of Global Health and Development
PubMed ID: 23030841
Web of Science ID: 311782100003
URI: http://researchonline.lshtm.ac.uk/id/eprint/2064763

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
291Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item